ID
16547
Description
MIPSO Vergleichende Untersuchung der bakteriellen Mikrobiota in der Haut sowie dem Darm von Psoriasis-Patienten vor und nach systemischer Behandlung mit Adalimumab bzw. Ustekinumab oder Ciclosporin (EudraCT 2014-003022-40) Principal Investigator: Prof. Dr. Dr. h.c. Thomas A. Luger
Keywords
Versions (2)
- 12/8/15 12/8/15 -
- 7/23/16 7/23/16 -
Uploaded on
July 23, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Adalimumab/Ustekinumab Psoriasis MIPSO EudraCT 2014-003022-40 DRKS00007147
Adalimumab/Ustekinumab Psoriasis MIPSO EudraCT 2014-003022-40
- StudyEvent: ODM
Description
Medication Adalimumab/Ustekinumab
Alias
- UMLS CUI-1
- C0013227
- UMLS CUI-2
- C1122087
- UMLS CUI-3
- C1608841
Description
Injection number
Data type
integer
Alias
- UMLS CUI [1,1]
- C1533685
- UMLS CUI [1,2]
- C0237753
Description
Injection date
Data type
date
Alias
- UMLS CUI [1,1]
- C1533685
- UMLS CUI [1,2]
- C0011008
Description
Injection dose
Data type
integer
Measurement units
- mg
Alias
- UMLS CUI [1,1]
- C1533685
- UMLS CUI [1,2]
- C3174092
Similar models
Adalimumab/Ustekinumab Psoriasis MIPSO EudraCT 2014-003022-40
- StudyEvent: ODM
C1608841 (UMLS CUI-2)
C1122087 (UMLS CUI-2)
C1608841 (UMLS CUI-3)
C0237753 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C3174092 (UMLS CUI [1,2])